Polyclonal Antibody to Cholecystokinin 4, Tetrapeptide (CCK4)
Trp-Met-Asp-Phe-NH2
- Product No.PAA378Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen RPA378Hu01-Recombinant Cholecystokinin 4, Tetrapeptide (CCK4)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- TraitsLiquid
- Concentration500µg/mL
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies. - DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
US$ 108
For more details, please contact local distributors! US$ 252 US$ 360 US$ 900 US$ 3600
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against CCK4. It has been selected for its ability to recognize CCK4 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA378Hu01 | Recombinant Cholecystokinin 4, Tetrapeptide (CCK4) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA378Hu01 | Polyclonal Antibody to Cholecystokinin 4, Tetrapeptide (CCK4) | WB; IHC; ICC; IP. |